Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are being investigated as potential therapies for coronavirus disease 2019 (COVID‐19). A thorough understanding of the current body of evidence regarding benefits and r...

詳細記述

書誌詳細
主要な著者: Piechotta, V, Iannizzi, C, Chai, KL, Valk, SJ, Kimber, C, Dorando, E, Monsef, I, Wood, EM, Lamikanra, AA, Roberts, DJ, McQuilten, Z, So-Osman, C, Estcourt, LJ, Skoetz, N
フォーマット: Journal article
言語:English
出版事項: Cochrane Collaboration 2021

類似資料